FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309598052> ?p ?o ?g. }

• W4309598052 abstract "BACKGROUNDAt the onset of exercise, the speed at which phosphocreatine (PCr) decreases toward a new steady state (PCr on-kinetics) reflects the readiness to activate mitochondrial ATP synthesis, which is secondary to Acetyl-CoA availability in skeletal muscle. We hypothesized that PCr on-kinetics are slower in metabolically compromised and older individuals and are associated with low carnitine acetyltransferase (CrAT) protein activity and compromised physical function.METHODSWe applied 31P-magnetic resonance spectroscopy (31P-MRS) to assess PCr on-kinetics in 2 cohorts of volunteers. Cohort 1 included patients who had type 2 diabetes, were obese, were lean trained (VO2max > 55 mL/kg/min), and were lean untrained (VO2max < 45 mL/kg/min). Cohort 2 included young (20-30 years) and older (65-80 years) individuals with normal physical activity and older, trained individuals. Previous results of CrAT protein activity and acetylcarnitine content in muscle tissue were used to explore the underlying mechanisms of PCr on-kinetics, along with various markers of physical function.RESULTSPCr on-kinetics were significantly slower in metabolically compromised and older individuals (indicating mitochondrial inertia) as compared with young and older trained volunteers, regardless of in vivo skeletal muscle oxidative capacity (P < 0.001). Mitochondrial inertia correlated with reduced CrAT protein activity, low acetylcarnitine content, and functional outcomes (P < 0.001).CONCLUSIONPCr on-kinetics are significantly slower in metabolically compromised and older individuals with normal physical activity compared with young and older trained individuals, regardless of in vivo skeletal muscle oxidative capacity, indicating greater mitochondrial inertia. Thus, PCr on-kinetics are a currently unexplored signature of skeletal muscle mitochondrial metabolism, tightly linked to functional outcomes. Skeletal muscle mitochondrial inertia might emerge as a target of intervention to improve physical function.TRIAL REGISTRATIONNCT01298375 and NCT03666013 (clinicaltrials.gov).FUNDINGRM and MH received an EFSD/Lilly grant from the European Foundation for the Study of Diabetes (EFSD). VS was supported by an ERC starting grant (grant 759161) MRS in Diabetes." @default.
• W4309598052 created "2022-11-28" @default.
• W4309598052 creator A5007221823 @default.
• W4309598052 creator A5016797998 @default.
• W4309598052 creator A5023656528 @default.
• W4309598052 creator A5049905804 @default.
• W4309598052 creator A5070391533 @default.
• W4309598052 creator A5076966741 @default.
• W4309598052 creator A5077744487 @default.
• W4309598052 creator A5087038295 @default.
• W4309598052 creator A5089438391 @default.
• W4309598052 date "2023-01-10" @default.
• W4309598052 modified "2023-09-30" @default.
• W4309598052 title "Skeletal muscle mitochondrial inertia is associated with carnitine acetyltransferase activity and physical function in humans" @default.
• W4309598052 cites W111397596 @default.
• W4309598052 cites W1692522137 @default.
• W4309598052 cites W1884000914 @default.
• W4309598052 cites W1956788262 @default.
• W4309598052 cites W1967206553 @default.
• W4309598052 cites W1981279991 @default.
• W4309598052 cites W1992592537 @default.
• W4309598052 cites W1995143186 @default.
• W4309598052 cites W2018108564 @default.
• W4309598052 cites W2030844090 @default.
• W4309598052 cites W2040281761 @default.
• W4309598052 cites W2041811148 @default.
• W4309598052 cites W2046886748 @default.
• W4309598052 cites W2054499492 @default.
• W4309598052 cites W2062229924 @default.
• W4309598052 cites W2088209140 @default.
• W4309598052 cites W2096657471 @default.
• W4309598052 cites W2105912552 @default.
• W4309598052 cites W2112906476 @default.
• W4309598052 cites W2116583199 @default.
• W4309598052 cites W2139894846 @default.
• W4309598052 cites W2160574264 @default.
• W4309598052 cites W2215994705 @default.
• W4309598052 cites W2269057620 @default.
• W4309598052 cites W2318201629 @default.
• W4309598052 cites W2789587938 @default.
• W4309598052 cites W2898401647 @default.
• W4309598052 cites W2950657114 @default.
• W4309598052 cites W2984620008 @default.
• W4309598052 cites W3047131348 @default.
• W4309598052 cites W3087694984 @default.
• W4309598052 doi "https://doi.org/10.1172/jci.insight.163855" @default.
• W4309598052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36413408" @default.
• W4309598052 hasPublicationYear "2023" @default.
• W4309598052 type Work @default.
• W4309598052 citedByCount "1" @default.
• W4309598052 countsByYear W43095980522023 @default.
• W4309598052 crossrefType "journal-article" @default.
• W4309598052 hasAuthorship W4309598052A5007221823 @default.
• W4309598052 hasAuthorship W4309598052A5016797998 @default.
• W4309598052 hasAuthorship W4309598052A5023656528 @default.
• W4309598052 hasAuthorship W4309598052A5049905804 @default.
• W4309598052 hasAuthorship W4309598052A5070391533 @default.
• W4309598052 hasAuthorship W4309598052A5076966741 @default.
• W4309598052 hasAuthorship W4309598052A5077744487 @default.
• W4309598052 hasAuthorship W4309598052A5087038295 @default.
• W4309598052 hasAuthorship W4309598052A5089438391 @default.
• W4309598052 hasBestOaLocation W43095980521 @default.
• W4309598052 hasConcept C121332964 @default.
• W4309598052 hasConcept C126322002 @default.
• W4309598052 hasConcept C134018914 @default.
• W4309598052 hasConcept C148898269 @default.
• W4309598052 hasConcept C185592680 @default.
• W4309598052 hasConcept C2777553358 @default.
• W4309598052 hasConcept C2778435403 @default.
• W4309598052 hasConcept C2778626300 @default.
• W4309598052 hasConcept C2779959927 @default.
• W4309598052 hasConcept C28859421 @default.
• W4309598052 hasConcept C2986317502 @default.
• W4309598052 hasConcept C55493867 @default.
• W4309598052 hasConcept C57600042 @default.
• W4309598052 hasConcept C62520636 @default.
• W4309598052 hasConcept C71924100 @default.
• W4309598052 hasConcept C86803240 @default.
• W4309598052 hasConceptScore W4309598052C121332964 @default.
• W4309598052 hasConceptScore W4309598052C126322002 @default.
• W4309598052 hasConceptScore W4309598052C134018914 @default.
• W4309598052 hasConceptScore W4309598052C148898269 @default.
• W4309598052 hasConceptScore W4309598052C185592680 @default.
• W4309598052 hasConceptScore W4309598052C2777553358 @default.
• W4309598052 hasConceptScore W4309598052C2778435403 @default.
• W4309598052 hasConceptScore W4309598052C2778626300 @default.
• W4309598052 hasConceptScore W4309598052C2779959927 @default.
• W4309598052 hasConceptScore W4309598052C28859421 @default.
• W4309598052 hasConceptScore W4309598052C2986317502 @default.
• W4309598052 hasConceptScore W4309598052C55493867 @default.
• W4309598052 hasConceptScore W4309598052C57600042 @default.
• W4309598052 hasConceptScore W4309598052C62520636 @default.
• W4309598052 hasConceptScore W4309598052C71924100 @default.
• W4309598052 hasConceptScore W4309598052C86803240 @default.
• W4309598052 hasIssue "1" @default.
• W4309598052 hasLocation W43095980521 @default.
• W4309598052 hasLocation W43095980522 @default.
• W4309598052 hasLocation W43095980523 @default.
• W4309598052 hasOpenAccess W4309598052 @default.
• W4309598052 hasPrimaryLocation W43095980521 @default.

• next